Entecavir Tablets IP 0.5 Mg – VIRENTA 0.5 Tablets

VIRENTA 0.5 Tablets
Composition:- Entecavir 0.5 Mg

VIRENTA 0.5 Tablets – Entecavir Tablets IP 0.5 Mg features Entecavir, a potent guanosine nucleoside analogue and a first-line choice for chronic hepatitis B treatment. It substantially lowers HBV DNA levels and promotes healthier liver tissue, thereby protecting liver function and preventing disease progression. Its high barrier to resistance, sustained antiviral action, and excellent safety profile make it a gold-standard therapy for managing HBV.

Key Points of Entecavir Tablets – VIRENTA 0.5 Tablets
• High Resistance Barrier – Maintains long-term viral suppression with minimal risk of mutations, making it ideal for extended HBV therapy.
• Powerful Antiviral Action – Inhibits all critical steps of HBV polymerase, including priming, reverse transcription, and DNA replication.
• Safe and Well-Tolerated – Low incidence of kidney or bone-related side effects, with once-daily dosing for improved patient adherence.

Can be Prescribed by:
• Hepatologists
• Gastroenterologists
• General Physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.